These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11370510)

  • 1. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
    Hahn DL
    N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis of bronchial asthma and chronic obstructive lung disease by the family physician. Ad hoc consensus group 'Diagnosis of asthma/chronic obstructive lung disease by the family physician'].
    van Schayck CP
    Ned Tijdschr Geneeskd; 1995 Sep; 139(39):1966-71. PubMed ID: 7477538
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating How Post-Bronchodilator Vital Capacities Affect the Diagnosis of Obstruction in Pulmonary Function Tests.
    Blagev DP; Sorenson D; Linares-Perdomo O; Bamberg S; Hegewald M; Morris AH
    Respir Care; 2016 Nov; 61(11):1523-1529. PubMed ID: 27624631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Greater decrease in lung function in COPD during continuous rather than during symptom-oriented bronchodilator medication].
    Geijer R
    Ned Tijdschr Geneeskd; 1993 Mar; 137(10):517. PubMed ID: 8455744
    [No Abstract]   [Full Text] [Related]  

  • 8. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol.
    Saleeby PR; Ziskind MM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary-function testing in the evaluation of bronchodilator agents.
    Menendez R; Kelly HW
    Clin Pharm; 1983; 2(2):120-8. PubMed ID: 6349904
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.
    Pratter MR; Irwin RS
    Arch Intern Med; 1988 Sep; 148(9):1909-10. PubMed ID: 3415402
    [No Abstract]   [Full Text] [Related]  

  • 12. Forced vital capacity, airway obstruction and survival in a general population sample from the USA.
    Burney PG; Hooper R
    Thorax; 2011 Jan; 66(1):49-54. PubMed ID: 20980245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations of the German Respiratory League for treatment of patients with chronic obstructive bronchitis and pulmonary emphysema].
    Wettengel R; Böhning W; Cegla U; Criée C; Fichter J; Geisler L; Fabel H; Köhler D; Konietzko N; Lindemann H
    Med Klin (Munich); 1995 Jan; 90(1):3-7. PubMed ID: 7885301
    [No Abstract]   [Full Text] [Related]  

  • 14. [When are bronchodilator agents sufficient in asthma/chronic obstructive pulmonary disease?].
    van Schayck CP; van Herwaarden CL; Folgering H; Akkermans R; van Weel C
    Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1580-3. PubMed ID: 7675140
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms for isolated volume response to a bronchodilator in patients with COPD.
    Cerveri I; Pellegrino R; Dore R; Corsico A; Fulgoni P; van de Woestijne KP; Brusasco V
    J Appl Physiol (1985); 2000 Jun; 88(6):1989-95. PubMed ID: 10846010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response: Utilization of FEV6 in place of FVC may lead to underestimation of mild airway obstruction.
    Demir T
    Respir Med; 2005 Dec; 99(12):1617. PubMed ID: 16291084
    [No Abstract]   [Full Text] [Related]  

  • 17. Don't diagnose mild COPD without confirming airway obstruction after an inhaled bronchodilator.
    Enright P; Quanjer P
    COPD; 2007 Jun; 4(2):89-90. PubMed ID: 17530501
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical observations of aerosol deposition in patients with airways obstruction.
    Itoh H; Ishii Y; Maeda H; Todo G; Torizuka K; Smaldone GC
    Chest; 1981 Dec; 80(6 Suppl):837-40. PubMed ID: 7307621
    [No Abstract]   [Full Text] [Related]  

  • 19. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.